• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肥大细胞增生症的分子背景、临床特征和治疗管理:2021 年现状。

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

机构信息

Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, 80-211 Gdańsk, Poland.

Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, 4031 Basel, Switzerland.

出版信息

Int J Mol Sci. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586.

DOI:10.3390/ijms22052586
PMID:33806685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961542/
Abstract

Pediatric mastocytosis is a heterogeneous disease characterized by accumulation of mast cells in the skin and less frequently in other organs. Somatic or germline mutations in the proto-oncogene are detected in most patients. Cutaneous mastocytosis is the most common form of the disease in children. In the majority of cases, skin lesions regress spontaneously around puberty. However, in few patients, mastocytosis is not a self-limiting disease, but persists into adulthood and can show signs of systemic involvement, especially when skin lesions are small-sized and monomorphic. Children with mastocytosis often suffer from mast cell mediator-related symptoms. Severe hypersensitivity reactions can also occur, mostly in patients with extensive skin lesions and blistering. In a substantial number of these cases, the triggering factor of anaphylaxis remains unidentified. Management of pediatric mastocytosis is mainly based on strict avoidance of triggers, treatment with H1 and H2 histamine receptor blockers, and equipment of patients and their families with epinephrine auto-injectors for use in severe anaphylactic reactions. Advanced systemic mastocytosis occurs occasionally. All children with mastocytosis require follow-up examinations. A bone marrow investigation is performed when advanced systemic mastocytosis is suspected and has an impact on therapy or when cutaneous disease persists into adulthood.

摘要

儿童肥大细胞增多症是一种异质性疾病,其特征是肥大细胞在皮肤中积累,在其他器官中较少见。大多数患者检测到原癌基因的体细胞或种系突变。在儿童中,皮肤肥大细胞增多症是最常见的疾病形式。在大多数情况下,皮肤病变会在青春期自发消退。然而,在少数患者中,肥大细胞增多症不是一种自限性疾病,而是持续到成年期,并可能出现系统性受累的迹象,特别是当皮肤病变为小尺寸和单形性时。患有肥大细胞增多症的儿童常患有肥大细胞介质相关症状。严重的过敏反应也可能发生,主要发生在广泛皮肤病变和水疱的患者中。在这些病例中的相当一部分中,过敏反应的触发因素仍然未知。儿童肥大细胞增多症的管理主要基于严格避免诱因、使用 H1 和 H2 组胺受体阻滞剂治疗以及为患者及其家属配备肾上腺素自动注射器,以用于严重过敏反应。偶尔会发生高级系统性肥大细胞增多症。所有患有肥大细胞增多症的儿童都需要进行随访检查。当怀疑发生高级系统性肥大细胞增多症且对治疗有影响或当皮肤疾病持续到成年期时,进行骨髓检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e29/7961542/9ecf0202711c/ijms-22-02586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e29/7961542/7e9924aeb74c/ijms-22-02586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e29/7961542/9ecf0202711c/ijms-22-02586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e29/7961542/7e9924aeb74c/ijms-22-02586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e29/7961542/9ecf0202711c/ijms-22-02586-g002.jpg

相似文献

1
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.儿童肥大细胞增生症的分子背景、临床特征和治疗管理:2021 年现状。
Int J Mol Sci. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586.
2
Pediatric Mastocytosis: An Update.儿童肥大细胞增多症:最新进展
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021069. doi: 10.4084/MJHID.2021.069. eCollection 2021.
3
[Mastocytosis in children].[儿童肥大细胞增多症]
Dermatologie (Heidelb). 2023 May;74(5):323-329. doi: 10.1007/s00105-023-05168-9.
4
Mastocytosis: a comprehensive insight.肥大细胞增多症:全面洞察
G Ital Dermatol Venereol. 2016 Aug;151(4):385-96. Epub 2016 Apr 12.
5
Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.色素性荨麻疹演变为惰性系统性肥大细胞增多症:肥大细胞免疫表型异常,无c-kit突变ASP-816-VAL证据
Leuk Lymphoma. 2003 Feb;44(2):313-9. doi: 10.1080/1042819021000037967.
6
[Systemic mastocytosis. Classification, symptoms, therapy].[系统性肥大细胞增多症。分类、症状、治疗]
Med Klin (Munich). 2004 Mar 15;99(3):131-6. doi: 10.1007/s00063-004-1021-x.
7
[Mastocytosis: revisited with new cytogenetic data].[肥大细胞增多症:基于新的细胞遗传学数据的重新审视]
Rev Med Brux. 2012 Jan-Feb;33(1):12-21.
8
Kit Mutations: New Insights and Diagnostic Value.试剂盒突变:新见解与诊断价值
Immunol Allergy Clin North Am. 2018 Aug;38(3):411-428. doi: 10.1016/j.iac.2018.04.005. Epub 2018 Jun 9.
9
[An infant with macules and papules].[一名患有斑疹和丘疹的婴儿]
Ned Tijdschr Geneeskd. 2020 Aug 17;164:D5098.
10
Mastocytosis and related disorders.肥大细胞病及相关疾病。
Semin Diagn Pathol. 2012 Feb;29(1):19-30. doi: 10.1053/j.semdp.2011.06.002.

引用本文的文献

1
Hereditary α-Tryptasemia and Peripheral Blood D816V Mutation in Patients with Pediatric Mastocytosis.儿童肥大细胞增多症患者的遗传性α-色氨酸血症与外周血D816V突变
Int J Mol Sci. 2025 Jun 23;26(13):6023. doi: 10.3390/ijms26136023.
2
Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis.儿童皮肤和系统性肥大细胞增多症中髓系基因改变的患病率。
Br J Haematol. 2025 Jun 19. doi: 10.1111/bjh.20214.
3
The Impact of Mast Cells on the Anatomy, Cellular Communication, and Molecular Immune Network of Lymph Nodes.

本文引用的文献

1
Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors.在一个与胃肠道间质瘤相关的家族性肥大细胞增多症家系中检测到种系KIT S476I突变。
J Allergy Clin Immunol Pract. 2021 May;9(5):2123-2125.e1. doi: 10.1016/j.jaip.2020.12.049. Epub 2021 Jan 7.
2
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.肥大细胞作为一种独特的造血谱系和细胞系统:从保罗·埃尔利希的愿景到精准医学概念。
Theranostics. 2020 Aug 29;10(23):10743-10768. doi: 10.7150/thno.46719. eCollection 2020.
3
Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
肥大细胞对淋巴结的解剖结构、细胞通讯及分子免疫网络的影响
Clin Rev Allergy Immunol. 2025 Apr 2;68(1):35. doi: 10.1007/s12016-025-09050-5.
4
A rare case of pediatric cutaneous bullous mastocytosis.小儿皮肤大疱性肥大细胞增多症1例罕见病例。
JAAD Case Rep. 2024 Dec 25;57:14-17. doi: 10.1016/j.jdcr.2024.11.041. eCollection 2025 Mar.
5
Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease.弥漫性皮肤肥大细胞增生症:一种罕见疾病的当前认识。
Int J Mol Sci. 2024 Jan 23;25(3):1401. doi: 10.3390/ijms25031401.
6
Bullous Mastocytosis: A Rare Variant of Diffuse Cutaneous Mastocytosis.大疱性肥大细胞增多症:弥漫性皮肤肥大细胞增多症的一种罕见变体。
Cureus. 2024 Jan 4;16(1):e51660. doi: 10.7759/cureus.51660. eCollection 2024 Jan.
7
Challenges in the Diagnosis of Cutaneous Mastocytosis.皮肤肥大细胞增多症的诊断挑战
Diagnostics (Basel). 2024 Jan 11;14(2):161. doi: 10.3390/diagnostics14020161.
8
Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis.小儿皮肤肥大细胞增多症诊断中的当前挑战
Diagnostics (Basel). 2023 Dec 1;13(23):3583. doi: 10.3390/diagnostics13233583.
9
Mastocytosis and Skin Cancer: The Current State of Knowledge.肥大细胞病与皮肤癌:当前知识状况。
Int J Mol Sci. 2023 Jun 7;24(12):9840. doi: 10.3390/ijms24129840.
10
Childhood Cutaneous Mastocytosis: Revisited.儿童皮肤肥大细胞增多症:再探讨
Indian J Dermatol. 2023 Jan-Feb;68(1):121. doi: 10.4103/ijd.ijd_264_22.
中国新生儿皮肤肥大细胞增多症的基因型和表型特征:一例报告及文献复习
J Int Med Res. 2020 Sep;48(9):300060520952621. doi: 10.1177/0300060520952621.
4
Pediatric mastocytosis.小儿肥大细胞增生症。
Curr Opin Pediatr. 2020 Aug;32(4):531-538. doi: 10.1097/MOP.0000000000000922.
5
Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.系统性肥大细胞增多症的分子生物学新进展:对诊断、预后和治疗的影响。
Int J Mol Sci. 2020 Jun 2;21(11):3987. doi: 10.3390/ijms21113987.
6
New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood.儿童肥大细胞增多症的新方法:外周血中 KIT D816V 突变检测的意义。
Acta Derm Venereol. 2020 May 28;100(10):adv00149. doi: 10.2340/00015555-3504.
7
Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.奥马珠单抗治疗成人肥大细胞增多症的系统评价。
Clin Exp Allergy. 2020 Jun;50(6):654-661. doi: 10.1111/cea.13592. Epub 2020 Mar 25.
8
Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.对小儿皮肤肥大细胞增多症患者,特别是野生型 KIT 患者的基因型和表型分析。
J Dermatol. 2020 Apr;47(4):426-429. doi: 10.1111/1346-8138.15266. Epub 2020 Feb 20.
9
Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).奥马珠单抗治疗肥大细胞增多症的疗效:来自前瞻性、双盲、多中心研究(XOLMA 研究)的暗示性结果。
Dermatology. 2020;236(6):529-539. doi: 10.1159/000504842. Epub 2020 Jan 20.
10
KIT D816V and the cytokine storm in mastocytosis: production and role of interleukin-6.KIT D816V与肥大细胞增多症中的细胞因子风暴:白细胞介素-6的产生及作用
Haematologica. 2020 Jan;105(1):5-6. doi: 10.3324/haematol.2019.234864.